ArticleJournal of computational biology : a journal of computational molecular cell biology2019
Deep Reinforcement Learning and Simulation as a Path Toward Precision Medicine.
Article in Journal of computational biology : a journal of computational molecular cell biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- A novel intelligent hybrid reinforcement learning framework for autonomous decision making in complex health cognitive systems.Scientific reports · 2026Article
- Real-time clinical analytics at scale: a platform built on large language models-powered knowledge graphs.JAMIA open · 2026Article
- Collaborative AI for precision neurorehabilitation: a roadmap.Journal of neuroengineering and rehabilitation · 2025Review
- Review
- Interaction between post-tumor inflammation and vascular smooth muscle cell dysfunction in sepsis-induced cardiomyopathy.Frontiers in immunology · 2025Article
- Modeling and control of COVID-19 disease using deep reinforcement learning method.Medical & biological engineering & computing · 2024Article
- Article
- The Wound Environment Agent-based Model (WEABM): a digital twin platform for characterization and complex therapeutic discovery for volumetric muscle loss.bioRxiv : the preprint server for biology · 2024Article
- Reinforcement learning informs optimal treatment strategies to limit antibiotic resistance.Proceedings of the National Academy of Sciences of the United States of America · 2024Article
- Deep reinforcement learning identifies personalized intermittent androgen deprivation therapy for prostate cancer.Briefings in bioinformatics · 2024Article
- A Reinforcement Learning Model for Optimal Treatment Strategies in Intensive Care: Assessment of the Role of Cardiorespiratory Features.IEEE open journal of engineering in medicine and biology · 2024Article
- Harnessing artificial intelligence in sepsis care: advances in early detection, personalized treatment, and real-time monitoring.Frontiers in medicine · 2024Review
- Reinforcement Learning informs optimal treatment strategies to limit antibiotic resistance.bioRxiv : the preprint server for biology · 2023Article
- Characterizing the Crosstalk Between Programmed Cell Death Pathways in Cytokine Storm With an Agent-Based Model.Surgical infections · 2023Article
- Embracing complexity in sepsis.Critical care (London, England) · 2023Review
- Artificial intelligence and its impact on the domains of universal health coverage, health emergencies and health promotion: An overview of systematic reviews.International journal of medical informatics · 2022Review
- High-dimensional role of AI and machine learning in cancer research.British journal of cancer · 2022Review
- Preparing for the next COVID: Deep Reinforcement Learning trained Artificial Intelligence discovery of multi-modal immunomodulatory control of systemic inflammation in the absence of effective anti-microbials.bioRxiv : the preprint server for biology · 2022Article
- Preparing for the next pandemic: Simulation-based deep reinforcement learning to discover and test multimodal control of systemic inflammation using repurposed immunomodulatory agents.Frontiers in immunology · 2022Article
- Drug Development Digital Twins for Drug Discovery, Testing and Repurposing: A Schema for Requirements and Development.Frontiers in systems biology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.